Recent Advances in Cancer Research from the 2010 ASCO Annual Meeting

Learn about recent advances from the American Society of Clinical Oncology's (ASCO) 2010 Annual Meeting (June 4-8, Chicago, Illinois), either in person or online:

Bay Area Breast Cancer Forum
Presents "ASCO 2010 (American Society of Clinical Oncology): News from the Annual Int'l Oncology Meeting"

Wednesday, June 16, 6:00-7:30 pm
UCSF Medical Center at Mt. Zion
1600 Divisadero St., H Bldg., 3rd floor conference room
Moderator: Hope Rugo, MD

The Bay Area Breast Cancer Forum is a monthly gathering of health care providers, researchers, patients, and patient advocates/friends/caregivers. Discussion will be accompanied by a light dinner.

This and other Bay Area Breast Cancer Forum events are also available by podcast.
For information, contact Lauren Metzroth, 415.885.7213.

---

Recent Advances in Lung Cancer, Melanoma, CML Research

Cancer.Net, the patient information website from the American Society of Clinical Oncology (ASCO), has information on recent advances shared at the 2010 ASCO Annual Meeting (June 4-8, Chicago, Illinois). The following studies highlight advances in lung cancer, melanoma, and chronic myeloid leukemia (CML). Linked below are easy-to-read summaries, as well as podcasts and videos that allow you to hear directly from leading oncologists about what these studies mean.

Lung Cancer

• Drug Combination Increases Survival for Older People With Advanced Lung Cancer
• Selenium Doesn't Prevent a Second Tumor for Patients With Non-Small Cell Lung Cancer
• New Drug Helps Manage Advanced Non-Small Cell Lung Cancer for Some Patients
  

To learn more about the findings of these studies, listen to a podcast or watch a video with Mark Kris, MD, professor of medicine at the Weill Medical College of Cornell University and chief of the thoracic oncology service at Memorial Sloan-Kettering Cancer Center.

See also, Cancer.Net's Guide to Lung Cancer.

Melanoma

• Drug Improves Survival for Patients With Advanced Melanoma

To learn more about the findings of this study, listen to a podcast or watch a video with Lynn Schuchter, MD, professor of medicine at the Hospital of the University of Pennsylvania and associate director of the Clinical Research Unit at Abramson Cancer Center.

See also, Cancer.Net's Guide to Melanoma.


CML

• Dasatinib More Effective than Imatinib for People Newly Diagnosed With Chronic CML

To learn more about the findings of this study, listen to a podcast or watch a video with Sonali Smith, MD, associate professor of medicine at the University of Chicago Medical Center.

See also, Cancer.Net's Guide to CML.

Tweet